11
TITLE: Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells
AUTHORS: Ferreira, Debora; Santos Pereira, Catia; Costa, Marta; Afonso, Julieta; Yang, Sujuan; Hensel, Janine; Mcandrews, Kathleen M.; Longatto Filho, Adhemar; Fernandes, Rui ; Melo, Joana B.; Baltazar, Fatima; Moreira, Joao N.; Kalluri, Raghu; Rodrigues, Ligia R.;
PUBLISHED: 2023, SOURCE: BIOMATERIALS ADVANCES, VOLUME: 154
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
12
TITLE: Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery
AUTHORS: Correia, A. C.; Moreira, J. N.; Lobo, J. M. Sousa; Silva, A. C.;
PUBLISHED: 2023, SOURCE: EXPERT OPINION ON DRUG DELIVERY, VOLUME: 20, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
13
TITLE: Current Insights on Lipid-Based Nanosystems 2023
AUTHORS: Silva, Ana Catarina; Moreira, Joao Nuno; Lobo, Jose Manuel Sousa;
PUBLISHED: 2023, SOURCE: PHARMACEUTICALS, VOLUME: 16, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
14
TITLE: Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma  Full Text
AUTHORS: Carvalheiro, M; Ferreira Silva, M; Holovanchuk, D; Marinho, HS; Moreira, JN; Soares, H; Corvo, ML; Cruz, MEM;
PUBLISHED: 2022, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 612
INDEXED IN: Scopus WOS CrossRef: 8
IN MY: ORCID
15
TITLE: New advances in exosome-based targeted drug delivery systems
AUTHORS: Ferreira, D; Moreira, JN; Rodrigues, LR;
PUBLISHED: 2022, SOURCE: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, VOLUME: 172
INDEXED IN: Scopus WOS CrossRef: 59
IN MY: ORCID
16
TITLE: Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer
AUTHORS: Valerio Fernandes, Angela; Fonseca, Nuno A.; Goncalves, Nelio; Cruz, Ana F.; Pereira, Marta I.; Gregorio, Ana C.; Moura, Vera; Ladeirinha, Ana F.; Alarcao, Ana; Goncalves, Joana; Abrunhosa, Antero; Melo, Joana B.; Carvalho, Lina; Simoes, Sergio; Moreira, Joao N.;
PUBLISHED: 2022, SOURCE: CANCERS, VOLUME: 14, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
17
TITLE: Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
AUTHORS: Cruz, Ana Filipa A.; Fonseca, Nuno A. B.; Malheiro, Ana Rita; Melo, Joana B.; Gaspar, Maria Manuela; Fernandes, Rui; Moura, Vera; Simoes, Sergio; Moreira, Joao Nuno;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, VOLUME: 172
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
18
TITLE: Endoscopic necrosectomy - When the gastroenterologist faces his greatest nightmare  Full Text
AUTHORS: Pimentel, Raquel; Almeida, Nuno; Figueiredo, Pedro;
PUBLISHED: 2022, SOURCE: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, VOLUME: 114, ISSUE: 7
INDEXED IN: Scopus WOS
19
TITLE: Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood- brain barrier (BBB) to manage neurological disorders  Full Text
AUTHORS: Correia, A. C.; Monteiro, A. R.; Silva, R.; Moreira, J. N.; Lobo, J. M. Sousa; Silva, A. C. ;
PUBLISHED: 2022, SOURCE: ADVANCED DRUG DELIVERY REVIEWS, VOLUME: 189
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
20
TITLE: Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
AUTHORS: Ribeiro, Rita; Carvalho, Maria Joao; Goncalves, Joao; Moreira, Joao Nuno;
PUBLISHED: 2022, SOURCE: FRONTIERS IN MOLECULAR BIOSCIENCES, VOLUME: 9
INDEXED IN: Scopus WOS CrossRef: 21
IN MY: ORCID
Page 2 of 13. Total results: 124.